Sign in to view content

48-Week End of Study Results From BEHOLD Phase 2 Study of UBX1325 in Patients With DME

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2023

Related

Artificial Intelligence Screening for Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists' Dilated Exams
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2020
Retinal Vascular Disease Take-Home Panel
Neil M. Bressler, MD
Annual Meeting Talks
2019
Suprachoroidal Delivery of RGX-314 for Diabetic Retinopathy Without CI-DME: Early Results From the Phase II ALTITUDE Study
Dennis M. Marcus, MD
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more